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Abstract  
 
Background: Many people are accessing digital self-help for mental health problems, often 
with little evidence of effectiveness. Social anxiety is one of the most common sources of 
mental distress in the population and many people with symptoms do not seek help for what 
represents a significant public health problem. 
 
Methods: Two group randomized controlled trial conducted in England between 11th May 
2016 and 27th June 2018. Adults with social anxiety symptoms who were not receiving 
treatment for social anxiety were recruited using online advertisements. All participants had 
unrestricted access to usual care and were randomized in a 1:1 ratio to either a web-based 
unguided self-help intervention based on cognitive-behavioural principles, or to a waiting list 
control group. All outcomes were collected through self-report online questionnaires. The 
primary outcome was the change in 17-item self-report Social Phobia Inventory (SPIN-17) 
score from baseline to 6 weeks using a linear mixed-effect model that used data from all 
timepoints (6 weeks, 3, 6, 12 months).  
 
Results: 2212 participants were randomized. Six were excluded from analyses as ineligible. 
Of the 2116 eligible randomized participants (mean age 37 years, 80% women), 70.1% 
(1484/2116) had follow-up data available for analysis, and 56.9% (1205/2116) had data on the 
primary outcome, although attrition was higher in the intervention arm. At 6 weeks the mean 
(95% CI, P value) adjusted difference in change in SPIN-17 score in the intervention group 
compared to control, was -1.94 (-3.13 to -0.75, P=0.0014), a standardised mean difference 
effect size of 0.2. The improvement was maintained at 12 months. Given the high drop-out, 
sensitivity analyses explored missing data assumptions and were consistent with the primary 
analysis finding. The economic evaluation demonstrated cost-effectiveness with a small health 
status benefit and a reduction in health service utilisation.  
 
Conclusions: For people with social anxiety symptoms who are not receiving other forms of 
help, this study suggests that an online self-help tool based on cognitive behavioural principles 
can provide a small improvement in social anxiety symptoms compared with no intervention, 
although drop-out rates were high.  
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Main text  
 
Effectiveness of a self-guided internet intervention for social 
anxiety symptoms in the general population: a randomized 
controlled trial. 
 
Introduction 
 
Many people are accessing digital tools for self-help for a range of mental health problems.[1] 
Social anxiety is one of the most common sources of mental distress in the population and 
represents a significant public health problem.[2] Social anxiety is characterised by a cluster 
of cognitive, behavioural and physiological symptoms including an intense and persistent fear 
of being negatively evaluated in social or performance situations, along with avoidance of such 
situations. The individual fears that they may act in such a way, or show anxiety symptoms, as 
to cause embarrassment or humiliation. A diagnosis of social anxiety disorder may be made 
when symptoms are persistent and lead to disruption of daily routine, and work or social life, 
or if the symptoms themselves cause marked distress. There is a spectrum of symptomatology 
in the general population and even subclinical symptoms which do not reach a clinical 
diagnostic threshold can cause substantial impairment.[3,4] 
 
Effective psychological and pharmacological treatments exist for social anxiety symptoms but 
many people with symptoms do not seek or receive these.[5–7] Self-guided digital tools have 
received much attention, given their potential for high scalability and low marginal cost, and 
since they offer the benefits of convenient access and anonymity to people with social anxiety 
symptoms who may not seek help through more traditional routes due to embarrassment or fear 
of scrutiny.[8] A 2014 meta-analysis of randomized controlled trials of unguided internet-based 
self-help for social anxiety disorder identified 5 studies (270 participants in total) showing 
evidence for effectiveness for these interventions with a pooled standardised mean difference 
of 0·66 (95% CI 0.39 to 0.94).[5] Subsequent trials using self-help interventions which use 
cognitive-behavioural approaches have found similar effect sizes (between group effect sizes 
ranging from 0.47 to 0.76).[9–14] Previous work has tended be relatively small scale (the 
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largest number of participants in the intervention group in any previous individual study was 
100[14]) and has generally been confined to cases of social anxiety of clinical severity, usually 
based on a structured interview assessment. Very little work has attempted to examine the value 
of unguided self-help in a real world context, where individuals self-select as requiring help 
with symptoms which may not reach a clinical threshold, but which may be causing them some 
level of distress, and who choose to access digital tools themselves, with no clinician contact 
at all. In this study we examine the effectiveness and cost-effectiveness of the self-help E-
couch social anxiety tool (described in detail below). This was chosen as it is a self-directed 
online intervention based on cognitive behavioural therapy principles including components of 
known effectiveness in face-to-face therapy. A previous laboratory-based comparative study 
of the E-couch social anxiety tool with 21 participants (mainly university students) in the E-
couch arm showed pre-test/post-test improvement in social anxiety measures.[15] 
 
We therefore undertook the first large-scale pragmatic randomized trial of an online self-guided 
cognitive-behavioural intervention for people with self-reported social anxiety symptoms in 
the general population. Our experimental hypothesis was that participants who received the 
intervention would have a greater improvement in symptoms of social anxiety, compared with 
participants who did not. 
 
Methods 
 
Trial design and participants 
A two-arm, parallel group randomized controlled trial was conducted to compare the 
effectiveness and cost-effectiveness of a web-based and mobile-optimised self-guided 
intervention with a waiting list control condition for treating social anxiety symptoms. The 
study received ethics approval from the University of Oxford Medical Sciences Inter-
Divisional Research Ethics Committee (MS-IDREC-C1-2015-167) and the Australian 
National University (ANU) Human Research Ethics Committee (Protocol 2015/229) and is 
registered on ClinicalTrials.gov (NCT02451878). All participants provided informed consent 
to take part in the study using a self-completion online form. Outcomes were assessed at 
baseline, 6 weeks, 3, 6 and 12 months. The main follow-up timepoints were chosen to measure 
immediate effect (6 weeks as the intervention was designed to be used over a 6 week period) 
and longer term outcomes (12 months), along with interim timepoints (3 months and 6 months) 
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to strengthen our repeated measures analysis and to support participant engagement. All study 
administration was conducted using automated online systems. The trial protocol is in 
Supplement 1. 
 
Recruitment was primarily through an online advertisement placed on the UK National Health 
Service (NHS) website. In addition, study advertisements seeking individuals with social 
anxiety symptoms were placed on University and charity websites and disseminated via email 
and social media. We aimed to capture people with a broad range of social anxiety symptoms 
in the general population, who were likely to be typical of those seeking help from self-directed 
digital tools. Interested potential participants completed an online screening questionnaire to 
assess eligibility. We excluded anyone currently receiving therapist-guided treatment for social 
anxiety disorder or who self-reported a diagnosis of schizophrenia or bipolar affective disorder. 
Initial inclusion criteria were: having access to the internet-based intervention; aged 18 or over; 
resident in England; having an email address and mobile telephone number (to receive study 
emails and text alerts) and an initial criterion of scoring in a ‘subclinical’ range of 13-19 on the 
Social Phobia Inventory (SPIN-17). We had initially chosen the 13-19 range with expert advice 
as this would in theory capture those scoring above the population mean score (11-12) while 
excluding those scoring above the commonly used threshold of 19 which indicates further 
assessment may be warranted (although this threshold does not represent a diagnosis). 
However early in recruitment it became apparent that the majority of people in the general 
population volunteering for this study scored much higher than this and the distribution of 
SPIN-17 scores meant that very few scored in the low range.  There was clear evidence of a 
high level of unmet need among individuals living with social anxiety symptoms in the 
community and not seeking help elsewhere. With advice from our independent Trial Steering 
Committee we therefore revised and re-registered the protocol (in line with good practice in 
clinical trials) to modify the inclusion criteria to include all individuals scoring 13 or more on 
SPIN-17, therefore capturing those in our hypothesised ‘subclinical range’ of 13-19, as well as 
those scoring more highly. We continued to exclude anyone receiving professional help and 
therefore the final sample represented adults in the general population who self-reported some 
level of social anxiety symptoms but who were not receiving treatment for social anxiety. 
Potentially eligible participants completed consent and 24 hours later they were sent an email 
link to self-complete their baseline measures using online questionnaires. 
 
Randomisation and masking 
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Once baseline measures had been completed, participants were randomized (1:1 ratio) to either 
the intervention group (E-couch) or the waiting list control group using a computer generated 
random number sequence run through an automatic online programme, using a block size of 2 
without stratification. Due to the nature of the intervention, participants were not blind to 
allocation. 
 
Interventions 
Given that this was a general population sample, all participants continued to receive usual 
care. Participants in the intervention arm were given access to a password-protected website 
which contained the E-couch Social Anxiety Module. The website was mobile optimised and 
could therefore be used on a smartphone with the look and feel of a dedicated app, or on a 
computer browser.  
 
Self-guided intervention 
The E-couch Social Anxiety Module is a self-directed interactive program based on cognitive 
behavioural therapy principles. The program is divided into six modules: a literacy section 
which provides information about the symptoms of social anxiety, types of available help, and 
effective treatments; and five toolkits comprising exposure practice, cognitive restructuring 
(modifying your thinking), attention practice, social skills training and relaxation. The content 
of the toolkits consists of evidence-based information, interactive exercises and workbooks, 
based on cognitive behavioural principles, and participants could complete the modules in any 
order. Participants were advised to access and use the intervention over the initial period of 6 
weeks (although they could work through the intervention at their own pace and were able to 
access it for the full 12-month duration of the study). ‘Ideal’ usage of the intervention would 
entail engagement with one new module each week and ongoing updates to diaries and 
workbooks based on the user’s real-life experiences. E-couch was developed by the e-hub team 
at the Australian National University National Institute for Mental Health Research. The 
intervention was adapted for this study to create a ‘stand-alone’ social anxiety intervention that 
was accessed via a password protected portal and with the usual E-couch branding removed. 
The program was adapted for a UK audience by removing Australian-specific terminology and 
undertaking user testing on the new version. No changes were made to the intervention during 
the study period.  
 
Waiting list control 
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Participants in the Control group were informed they had been put on a waiting list to receive 
access to the intervention in 12 months. They were asked to complete baseline and follow-up 
measures at the same times as participants in the intervention group. They received no other 
intervention.  
 
Automated text (SMS) message and email reminders were sent to participants in both groups 
to reduce attrition. Participants in the intervention condition received one text message within 
24 hours of randomization to remind them to access the intervention, and three email reminders 
during the 6-week intervention period, reminding them to log in to access the program.  All 
participants also received email invitations to complete follow-up surveys at each outcome 
measure timepoint, with those who failed to complete receiving a reminder email followed by 
a reminder text message. 
  
Outcomes 
The primary outcome was the change in Social Phobia Inventory (SPIN-17) score from 
baseline to 6 weeks. The SPIN-17 is a 17-item self-rated scale covering the main social anxiety 
symptoms of fear, avoidance and physiological disturbance. The responses to 17 statements 
(such as ‘I avoid talking to people I don’t know’) are rated on a 5-point scale from ‘not at all’ 
(score=0) to ‘extremely’ (score=4) to indicate the extent to which each statement reflects how 
the respondent was feeling in the past week, with higher scores reflecting greater social anxiety 
symptoms. The SPIN-17 has good test-retest reliability, internal consistency, convergent and 
divergent validity.[16] Secondary outcomes were all also self-report measures with good 
reliability and validity: the 8-item Brief Fear of Negative Evaluation (BFNE-S scale) which is 
very commonly used in studies of social anxiety and measures one of the key psychological 
constructs of social anxiety (example item: ‘I am frequently afraid of other people noticing my 
shortcomings’);[17] the 20-item Centre for Epidemiologic Studies Depression scale (CES-D) 
which has been widely used in online studies of anxiety and depression interventions to 
measure depressive symptoms;[18] the 7-item Short Warwick-Edinburgh Mental Well-Being 
Scale (SWEMWBS) which is a measure of mental wellbeing requiring participants to provide 
the extent of their agreement with statements about thoughts and feelings over the previous 2 
weeks, which has been shown to be responsive to change (example item: ‘I’ve been feeling 
useful’);[19,20] and the widely used and validated 36-item Short Form Health Survey (SF36 
version 1) to measure health status and quality of life expressed in mental and physical 
component scores.[21] We also measured usage of the intervention in terms of number of E-
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couch modules completed, total time in minutes spent on modules and total page views. 
Adverse events were not anticipated but participants were asked to self-report any ill-effects 
thought to be related to the intervention.  
 
Sample size 
We aimed to recruit 2104 participants (i.e. 1052 per group) to this trial, to detect a small 
between group standardised mean difference of 0.2 at 5% two-sided significance level and 90% 
power, assuming a high level of potential attrition of up to 50% given the fully self-guided 
nature of the intervention and automated nature of the trial (all trial procedures were conducted 
online). Although, previous studies have suggested a larger treatment effect for internet-
delivered interventions, we believed this treatment effect is too optimistic for a pragmatic trial 
of a self-guided treatment in a general population sample. The target effect size, although small 
at an individual level, can potentially translate into important population-level change.[22] 
 
Statistical analyses 
The statistical analysis was finalised prior to unblinding of the data. Primary analysis was 
modified intention to treat according to allocated group irrespective of adherence and with at 
least one outcome questionnaire completed post randomization. . A linear mixed-effect model 
was fitted to the primary outcome data, utilising data collected at 6 weeks, 3, 6, and 12 months. 
Participant was included as a random intercept. Randomized group, baseline SPIN-17 score, 
time, and time by randomized group interaction term were fitted as fixed effects. An 
unstructured variance covariance matrix was specified between repeated measures on the same 
individual. Assumptions of normality and constant variance for linear mixed effects models 
were assessed by residual plots and other diagnostics plots.   
Given the high level of attrition expected in online trials of self-guided digital interventions, 
we also prespecified a Complier Average Causal Effect (CACE) analysis for the primary 
outcome and two other main outcomes, to include only participants who completed at least one 
module of the intervention and at least one outcome assessment to investigate the effect of the 
intervention in participants who adhered to the intervention. An instrumental variable approach 
was adopted to provide the CACE estimate at 6 weeks. This method involved a two least 
squares (using the ‘ivregress 2sls’ command in STATA) estimation from fitting a linear 
regression model of the primary outcome adjusting for baseline SPIN-17 and compliance 
instrumented on randomized group.[23]  
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Similar approaches were undertaken for other outcomes. A CACE analysis at 6 weeks was 
conducted on fear of negative evaluation (BFNE-S) and mental wellbeing (SWEMWBS) 
measures.  Similarly adjusting for baseline BFNE-S and SWEMWBS in the linear regression 
models. Safety analyses were not conducted as there were no adverse events reported during 
the study period. 
 
In anticipation of high levels of dropout we prespecified various sensitivity analyses to explore 
the impact of assumptions regarding missing data in the primary outcome analysis.  These 
included analyses of: (1) participants with complete data at all time periods; (2) adjusting for 
factors found to be predictive of missingness; (3) fitting a pattern mixture model to assess 
different degrees of missing not at random; and (4) an assessment of missing not at random 
assumption for the primary outcome by assuming plausible arm specific differences of missing 
SPIN-17 score between responders (with SPIN-17 score at 6 weeks) and non-responders 
(missing SPIN-17 score at 6 weeks). [24,25] 
 
Predefined subgroup analyses were conducted on change at 6 weeks for SPIN-17, BFNE-S, 
CES-D and SWEMWBS for baseline SPIN-17 (<19, ≥19) to see if the benefit differed between 
groups scoring above or below the screening threshold; and for certain demographic 
characteristics to see if the effectiveness of the intervention differed by the individual 
characteristics we had measured of age (≤35, >35), gender (male, female), educational level 
(degree, no degree) and ethnicity (any white, non-white). Subgroup analyses were conducted 
by inclusion of an interaction term of baseline subgroup by randomized group by time in the 
linear mixed model. Descriptive statistics were used to describe usage data, adherence and self-
reports of other help received during the study period. The statistical analysis plan is in 
Supplement 2. All statistical analyses were performed using STATA SE version 15.1.[26] 
 
Economic Evaluation  
A cost utility analysis from an NHS and social care perspective was conducted within this trial 
to assess the cost effectiveness of the intervention. The total costs of developing, modifying, 
delivering and maintaining the intervention were obtained, and the mean intervention cost was 
estimated for the participants recruited in the intervention group. Health care service utilization 
data (for any reasons) were collected for all participants, including: primary care consultations; 
hospital outpatient appointments; and hospital admissions. Unit costs for these health services 
were obtained from the Personal Social Services Research Unit (PSSRU, 2016 - 2017) using 
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national average costs.[27] Maximum follow up was one year and therefore no discounting 
was applied. The total and mean costs for the intervention and the waiting list control group 
were calculated. Effectiveness was measured in Quality-adjusted life years (QALYs) using the 
under the curve approach by combining the duration of follow-up with the health status utilities 
at the start and end points. Health status was measured using the self-reported SF-36 measure 
at baseline, 6 weeks, 3, 6 and 12 months. The analysis examined short term (6 weeks) and long 
term (12 months) impact. Health status utilities were converted from SF-36 to SF-6D indices 
using the established UK-based utility algorithm obtained through University of Sheffield 
Licensing.[28] The primary outcome was the incremental cost per QALY gained between the 
intervention group at 6 weeks and 12 months.   
 
 
Results 
Participant characteristics and trial flow 
Recruitment took place between 11th May 2016 and 9th May 2017 when the target sample size 
was reached. Participants were followed-up for one year. Final data were locked on 27th June 
2018 (allowing time for delayed 12 month follow-up responses). Figure 1 shows the flow 
diagram of the participants throughout the study period. We screened 9447 participants of 
whom 5932 (62.8%) were ineligible and a further 1393 (14.7%) did not complete the baseline 
measures. We randomized 1061 (50.0%) participants to E-couch and 1061 (50.0%) to the 
Control. Six participants who were randomized into the study were excluded from all analyses 
as their later responses indicated they did not meet the inclusion criteria in terms of age, leaving 
2116 participants randomized and included in analyses. Table 1 shows the baseline 
characteristics which were similar across both groups. As noted in Figure 1, due to a software 
error, many participants were not sent the email requesting completion of their interim (3 
month or 6 month) outcome measures. This error did not affect emails sent at the main follow-
up timepoints of baseline, 6 weeks and 12 months, and data from all timepoints were included 
in the analysis. Attrition rates differed significantly between groups with an overall loss to 
follow-up at the main follow-up timepoint (6 weeks) of 42.9%, with a loss of 60.8% in the 
intervention arm and 25.3% in the control arm (see Figure 1 and Supplement 3, eTables 1 and 
2). By 12 months the primary outcome was available for 349/1061 (32.9%) in the intervention 
group and 710/1061 (66.9%) in the control group. 
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Primary outcome 
Over the study period, there was a reduction of social anxiety symptoms in the E-couch group 
compared with the Control group (Table 2).  At 6 weeks the E-couch group had a mean (SD) 
reduction of SPIN-17 score of -6.2 (10.8) and the control group of -3.99 (9.3).  The adjusted 
difference mean (95% CI, P value) in change in SPIN-17 score in E-couch compared to control  
was -1.94 (-3.13 to -0.75, P=0.0014) (Table 3). This equates to a standardised mean difference 
effect size (between groups) of 0.2 (the pooled standard deviation for SPIN-17 change was 
9.81). At 6 weeks follow-up SPIN-17 outcome measures were available for 415 (39%) and 790 
participants (75%) in E-couch and Control group respectively. In the CACE analysis, adjusted 
mean difference (95% CI, P value) in change in SPIN-17 score for intervention compared to 
control was -2.95 (-4.30 to -1.61, P<0.0.001) (Table 3). The results from the sensitivity 
analyses undertaken to explore missing data assumptions were also consistent with the primary 
outcome 6 week findings. These included analyses which only considered data from 
completers (defined as participants who returned all their outcome measures at the main 
timepoints of baseline, 6 weeks and 12 months) (see Supplement 2, eTables 5, 7, 8), and the 
findings of the pattern mixture model even when assuming different missing data patterns in 
the intervention or control group (see Supplement 2, eFigure 1). Finally, findings were also 
similar to the primary outcome analysis even under the assumption of missing not at random 
(Supplement 2, eTable 10).   
 
Secondary outcomes 
Table 3 shows the results for the secondary outcomes. At 12 months follow-up participants 
randomized to the E-couch group continued to show a greater reduction in severity of social 
anxiety symptoms than the control participants, with a mean (95% CI, P value) adjusted 
difference in change in SPIN-17 score of -3.07 (-4.32 to -1.82); P<0.0001) (Table 3).  As with 
the primary outcome, the results of the sensitivity analyses exploring missing data assumptions 
were consistent with the main analysis SPIN-17 findings at 12 months (Supplement 3, eTables 
5, 7, 8). The findings for the other outcome measures of fear of negative evaluation (BFNE-S), 
mental wellbeing (SWEMWBS), depression (CES-D) and the mental component scale of the 
SF-36 all showed statistically significant small improvements favouring E-couch compared to 
Control (see Table 3). There was no evidence of difference between groups for the physical 
component scale of the SF-36. All distributions of residuals from the fitted models satisfied the 
normality assumption.  No adverse events were reported during the study period. 
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Usage data and subgroup analyses 
At 6 weeks the mean (SD) number of E-couch modules fully completed (out of six) was 2 
(1.43), total mean (SD) time in minutes spent on modules was 35 (48) and total mean (SD) 
page views was 38 (41). Greater adherence to the intervention was not associated with baseline 
SPIN-17 score, age, gender or ethnicity (Supplement 3, eTable 14). At 6 weeks, higher total 
page views or longer duration spent on modules was associated with larger improvement in 
social anxiety symptoms (Supplement 3, eTable 15). At 6 weeks, E-couch had a significantly 
greater impact in improving social anxiety symptoms for participants with baseline SPIN-17 
score greater than 19 (usually taken as cut-off to indicate clinical assessment warranted) 
compared with the few participants scoring in the lower range (SPIN-17 score 13-19) 
(P=0.0135) (Supplement 3, eFigure 2). In this subgroup analysis the lower SPIN-17 scorers 
(the ones we had originally defined as a subclinical population) had no benefit from the 
intervention compared with the control group. The E-couch intervention also had a 
significantly greater beneficial impact on depressive symptoms at 6 weeks in participants with 
higher baseline SPIN-17 scores (P=0.0070) and again in this subgroup analysis the few 
participants scoring in the lower SPIN-17 range had no benefit on depressive symptoms 
compared with the control group. There was no evidence of heterogeneity in the effects of 
intervention for the subgroups analyses involving BFNE-S and SWEMWBS.  
 
Economic evaluation 
At both 6 weeks and 12 months follow up, the waiting list control group in general used more 
health care services than the E-couch group (Table 4). This resulted in a mean health care cost 
saving of £26.48 at 6 weeks follow up and £65.04 at 12 months follow up. Adding the mean 
intervention cost of £48.40 to the intervention group, the E-couch group cost more than the 
control group at 6 weeks but is cost saving at 12 months. In the cost utility analysis, at both 6 
weeks and 12 months follow up, there were very small improvements of general health status 
in both the E-couch group and the waiting list control group, with the E-couch group 
improvement slightly more than the control group: the SF-6D indices increased from 0.6 at 
baseline to 0.64 at 6 weeks and 0.66 at 12 months for the E-couch group and from 0.6 at 
baseline to 0.62 at 6 weeks and 0.64 at 12 months for the waiting list control group. At 6 weeks 
follow up, mean QALYs were 0.072 for the E-couch group and 0.070 for the control group, 
giving very small QALYs gain of 0.002 for the intervention over the control group. At 12 
months follow up, mean QALYs were 0.635 for the E-couch group and 0.621 for the control 
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group, with QALYs gain of 0.024 for the intervention over the control group. The incremental 
cost per QALY gained at 6 weeks was £10,960 which is highly likely to be cost effective using 
accepted thresholds. At 12 months follow-up, the E-couch dominated the waiting list control 
with more QALYs gained and less costs. Taking into consideration societal costs due to sick 
leave from work, the E-couch intervention was cost saving at both 6 weeks and 12 months 
follow up, and therefore dominated the waiting list control.  
 
 
Discussion 
Principal results 
Our findings showed that this fully self-guided internet intervention gave a small reduction in 
social anxiety symptoms in participants recruited online from the general population, compared 
with a usual care waiting list control group, and this small but positive finding was robust to 
the sensitivity analyses which explored our missing data assumptions. There was a similarly 
small but significant improvement in fear of negative evaluation. These improvements were 
also found in the CACE analyses and maintained at 12 months follow-up. In the context of a 
very common mental health problem, this finding suggests that automated self-help delivered 
via the internet could reduce the overall level of social anxiety symptoms in the population, 
although at an individual level the mean symptomatic benefit is small (d=0.2). The study 
findings provide no evidence as to whether this fully self-guided approach has a role in a 
clinical setting, where, to date, the evidence base suggests that while unguided self-help has 
effectiveness, therapist-guided and therapist-led approaches are likely to be superior. The cost 
effectiveness analysis demonstrated that the intervention is likely to be cost effective in both 
the short and long term, although the gain in general health status and QALY score was very 
small. The benefit seen in the condition-specific social anxiety outcome measures was greater 
than the general health status used in the cost utility analysis. Furthermore, the intervention 
cost could be substantially reduced if the E-couch is used by large numbers at a population-
level as a public health tool. Given that many people with social anxiety symptoms do not seek 
help, and that therapist supported approaches are limited in supply, the findings suggest that 
unguided digital intervention for social anxiety can be beneficial for some people who do not 
access professional help and who are increasingly seeking support from apps and other digital 
tools. The self-help approach tested here might also complement face-to-face therapy, 
potentially reducing the amount of therapist contact time required and perhaps helping to 
 15 
maintain engagement, although these suggestions need to be empirically tested in future 
effectiveness and cost-effectiveness work. 
 
Comparison with prior work 
This study adds to the body of work showing small positive effects for unguided digital self-
help for social anxiety,[5,9–14] and a range of other mental health problems.[29] Our effect 
size is smaller than others have reported. Previous studies have had far fewer participants and 
usually required them to meet diagnostic criteria for social anxiety disorder. Our aim was to 
undertake a pragmatic trial addressing social anxiety symptoms (rather than disorder) among 
individuals in the general population. Our broad inclusion criteria, recruiting volunteers from 
the general population through internet adverts, including those with symptoms not reaching a 
diagnostic threshold, are likely to have contributed to the more modest benefit compared with 
previous work. We made the additional decision to conduct the trial in a fully automated and 
naturalistic way with no researcher contact to encourage intervention use. Our approach was 
intended to reflect the real world situation of members of the public self-selecting digital tools 
and using them with no contact with health services.  
 
Strengths and limitations 
This study exemplifies both the strengths and weaknesses of undertaking online trials for 
digital interventions. We were able to recruit large numbers of participants from the general 
population using digital advertising and we were able to deliver all measures and the 
intervention remotely using little resource and with no requirement for any ‘real world’ contact 
between participants and researchers. The flipside of this was that, in common with other fully 
automated trials of unguided online interventions, there were high levels of drop-out from the 
intervention and attrition from the trial.[30] This is commonly seen in internet research,[31] 
including the higher level of retention in the control arm,[32] which may be partly explained 
by these participants being on a waiting list and therefore having an incentive to keep returning 
to complete measures, and partly by participants in the intervention arm being required to ‘take 
action’ (work through the intervention) whereas the control group could be more passive. Other 
possible reasons for dropout include some participants not liking the intervention, or feeling it 
was not working, or indeed dropping out because they felt they had improved and no longer 
needed it. The high loss to follow-up was compounded at the 3 and 6 month follow-up points 
by a software glitch which reduced the number of emails sent to participants at this time. 
Fortunately these were always intended as interim timepoints measured to contribute to the 
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overall mixed linear model. We undertook sensitivity analyses and explored various 
approaches to adjusting for the missing data. All outcome measures were self-report with no 
observer-rated objective assessment. This was in line with our desire to deliver a fully 
automated trial, and the scales are well validated but the subjective nature of these measures is 
a potential source of response bias. We did not employ a placebo but instead used a waiting 
list comparator whereby people received ‘usual care’. In other work, educational website 
placebos have often demonstrated an active effect.[33] Our pragmatic choice of control group, 
given that participants were not blind to allocation, may have introduced bias and increased the 
likelihood of a beneficial effect. Finally, the majority of the participants in the current study 
(80%) were women.  Social anxiety symptoms are twice as common in women than men,[4] 
and women are more likely to seek healthcare generally.[34] Further work on the predictors 
and mediators of both adherence and response would be valuable.[35,36] 
 
Conclusions 
For people with social anxiety symptoms in the general population who are not receiving other 
forms of help, an online unguided tool based on cognitive behavioural principles accessed via 
a computer or mobile phone gave a small but significant improvement in social anxiety 
symptoms compared with no intervention. As with many online trials of digital interventions, 
we experienced a ‘methodological trade-off’ between having a cheap, scalable model of 
intervention delivery versus the statistical challenge of a high degree of missing data. Our 
findings suggest this intervention could potentially offer the first self-help rung on the ladder 
of a stepped approach to social anxiety symptoms. 
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Screened for eligibility (n=9447) 
 
Randomized (n=2122) 
 
E-Couch social anxiety module (n=1061) 
 
 
Excluded (n=7325) 
 Did not meet inclusion criteria (n=5932), multiple 
criteria possible: 
SPIN score >19 = 1923 (criterion later removed)  
In treatment = 1682 
Did not complete screening = 1203 
Did not provide contact details = 451 
Diagnosis of bipolar or schizophrenia = 436 
SPIN score <13 = 360 
Under 18 = 172 
Outside UK = 126 
Did not consent = 99 
•   Did not complete baseline survey (n=1393) 
 
Excluded (n = 88) 
 Not eligible (n = 3) 
 Lost to follow-up (n=85) 
- Reason not given = 73 
- Personal problems = 2 
- Lack of time = 5 
- Does not require help= 3 
- Unwell= 2 
 
Reached 6 weeks (n=973)  
 SPIN available (n=415) 
 
Reached 6 weeks (n=1042)  
 SPIN available (n=790) 
 
Lost to follow-up (n=5) 
     Reason not given = 4 
       No access to internet = 1 
       Does not require help = 0 
 
Lost to follow-up (n=8) 
      Reason not given = 7 
      No access to internet = 0 
      Does not require help = 1 
  
Reached 3 months (n=965)  
 SPIN available (n=174)a 
 
Reached 3 months (n=1037)  
 SPIN available (n=428)a 
 
Reached 6 months (n=963)  
 SPINa available (n=265) 
 
Reached 6 months (n=1035)  
 SPINa available (n=622) 
 
Reached 12 months (n=960)  
 SPIN available (n=349) 
 
Reached 12 months (n=1032)  
 SPIN available (n=710) 
 
Number included in primary analysis = 563 
Number with primary outcome = 415 
 
Number included in primary analysis = 921 
Number with primary outcome = 790 
 
Lost to follow-up (n=2) 
      Reason not given = 2 
  
Lost to follow-up (n=2) 
      Reason not given = 2 
  
Lost to follow-up (n=3) 
      Reason not given = 3 
  
Lost to follow-up (n=3) 
      Reason not given = 3 
  
Control  (n=1061) 
  
Excluded (n = 19) 
 Not eligible(n = 3) 
 Lost to follow-up (n=16) 
- Reason not given= 16 
- Personal problems= 0 
- Lack of time= 0 
- Does not require help=0 
- Unwell= 0 
 
FIGURE 1 
CONSORT flow diagram 
 
 
 
  
adue to a software error, many participants were not sent the email requesting completion of their interim (3 month or 6 
month) outcome measures. This error did not affect emails sent at the main follow-up timepoints of baseline, 6 weeks and 12 
months 
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TABLE 1 BASELINE CHARACTERISTICS OF ALL PARTICIPANTS RANDOMIZED 
Baseline Characteristics E-Couch  
(N = 1058) 
Control  
(N = 1058) 
Total Randomized 
(N = 2116)  
Age (years)    
Mean (SD) 37.4 (13.9) 36.9 (13.6) 37.17 (13.8) 
[Range] [18 to 84] [18 to 82] [18 to 84] 
Gender    
Female, n(%) 859 (81.2) 839 (79.3) 1698 (80.3) 
Male, n(%) 187 (17.7) 213 (20.1) 400 (18.9) 
Other, n(%) 10 (1.0) 6 (0.6) 16 (0.8) 
Missing, n(%) 2 (0.2) 0 (0) 2 (0.1) 
Marital Status     
Married or in a civil partnership, n(%) 327 (30.9) 311 (29.4) 638 (30.1) 
Not married, n(%) 727 (68.7) 745 (70.4) 1472 (69.6) 
Missing, n(%) 4 (0.4) 2 (0.2) 6 (0.3) 
Education    
Degree, n(%)  514 (48.6) 538 (50.9) 1052 (49.7) 
No Degree, n(%) 544 (51.4) 520 (49.1) 1064 (50.3) 
Employment Status    
Employed, n(%) 610 (57.7) 623 (58.9) 1233 (58.3) 
Unemployed, n(%) 440 (41.6) 426 (40.3) 866 (40.9) 
Missing, n(%) 8 (0.7) 9 (0.8) 17 (0.8) 
Income    
≤ £25,000, n(%) 736 (69.6) 739 (69.8) 1475 (69.7) 
> £25,000, n(%) 322 (30.4) 319 (30.2) 641 (30.3) 
Ethnicity    
White, n(%) 917 (86.7) 918 (86.8) 1835 (86.7) 
Non-white, n(%) 141 (13.3) 140 (13.2) 281 (13.3) 
Social Phobia Inventory (SPIN-17)    
Mean (SD) 39.6 (13.1) 39.8 (13.4) 39.7 (13.3) 
[Range] [13 to 68] [13 to 68] [13 to 68] 
Mental well-being score (SWEMWBS)    
Mean (SD) 17.7 (3.1) 17.7 (3.3) 17.7 (3.2) 
[Range] [7.0 to 30.7] [7.0 to 35.0] [7.0 to 35.0] 
Brief fear of negative evaluation score (BFNE-S)    
Mean (SD) 22.5 (7.1) 22.4 (7.3) 22.4 (7.2) 
[Range] [0 to  32] [0 to 32] [0 to 32] 
Centre for Epidemiologic Studies Depression 
scale (CES-D) 
   
Mean (SD) 30.5 (12.3) 30.7 (12.2) 30.6 (12.2) 
[Range] [2 to 60] [0 to 58] [0 to 60] 
Short Form – 36 Physical Component Summary 
(PCS) 
   
Mean (SD) 50.2 (10.3) 49.8 (10.6) 50.0 (10.4) 
[Range] [12.2 to 69.3] [16.8 to 67.3] [12.2 to 69.3] 
Short Form – 36 Mental Component Summary 
(MCS) 
   
Mean (SD) 49.9 (9.5) 50.1 (9.4) 50.0 (9.5) 
[Range] [29.3 to 77.1] [30.8 to 83.9] [29.3 to 83.9] 
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TABLE 2 DESCRIPTIVE STATISTICS OF SPIN-17 SCORE AT ALL TIME POINTS BY RANDOMIZED GROUP 
 SPIN-17a BFNE-S CES-D SWEMWBS SF-36 (PCS) SF-36 (MCS) 
 E-Couch  
N = 1058 
Control 
N = 1058 
E-Couch  
N = 1058 
Control 
N = 1058 
E-Couch  
N = 1058 
Control 
N = 1058 
E-Couch  
N = 1058 
Control 
N = 1058 
E-Couch  
N = 1058 
Control 
N = 1058 
E-Couch  
N = 1058 
Control 
N = 1058 
Baseline             
n 1058 1058 1058 1058 1058 1058 1058 1058 1058 1058 1058 1058 
Mean (SD) 39.61 
(13.14) 
 39.83 
(13.43) 
22.49 (7.11) 22.4 (7.32) 30.50 
(12.26) 
30.72 (12.19) 17.71 (3.10) 17.73 (3.32) 50.17 (10.29) 49.81 (10.60) 49.94 (9.48) 50.06 (9.44) 
[Range] [13 to 68] [13 to 68] [0  to 32] [0  to 32] [2 to 60] [0 to 58] [7 to 31] [7 to 35] [12.2 to 69.3] [16.8 to 67.3] [29.3 to 77.1] [30.9 to 83.9] 
6 weeks             
n 415 790 397 778 385 762 384 761 376 752 376 752 
Mean (SD) 32.57 
(13.46) 
35.78 
(14.31) 
20.24 (7.96) 21.69 (8.21) 23.50 (9.35) 28.27 (13.23) 18.88 (3.89) 18.26 (3.86) 49.73 (10.69) 49.73 (10.70) 51.19 (9.33) 49.38 (9.48) 
[Range] [2 to 65] 
 
[0 to 68] [1 to 32] 
 
[0  to 32] [7 to 54] 
 
[1 to 60] [7 to 35] 
 
[7 to 35] [15.9 to 70.2] 
 
[16.4 to 68.5] [30.7 to 78.3] 
 
[21.1 to 73.8] 
Mean (SD) change from 
baseline 
[Range] 
-6.20 
(10.76) 
[-48 to 23] 
-3.99 (9.28) 
[-46 to 34] 
 -1.79 (6.12) 
[-24 to 17] 
-0.50 (5.10) 
[-32  to 27] 
-5.58 (9.77) 
[-36 to 21] 
-2.22 (9.45) 
[-41 to 29] 
0.95 (3.15) 
[-8.8 to 16.4] 
0.49 (2.84) 
[-9.2 to 14.3] 
0.84 (6.44) 
[-21.0 to 
21.1] 
0.40 (6.23) 
[-27.8 to 23.7] 
-0.16 (8.42) 
[-25.9 to 
29.6] 
-0.97 (7.54) 
[-28.7 to 
23.3] 
3 monthsb             
n 174 428 171 419 168 414 167 413 166  402 166  402 
Mean (SD) 30.15 
(14.82) 
34.31 
(14.41) 
18.65 (8.77) 21.54 (8.39) 23.53 
(13.86) 
27.00 (12.73) 19.42 (4.41) 18.32 (3.92) 49.83 (9.75) 50.06 (10.58) 52.47 (9.60) 48.94 (9.22) 
[Range] [4 to 65] 
 
[0  to 68] [0 to 32] 
 
[0  to 32] [2 to 59] 
 
[0 to 58] [7 to 33] 
 
[7 to 35] [21.8 to 68.2] 
 
[19.2 to 66.8] [27.6 to 73.6] 
 
[27.5 to 72.8] 
Mean (SD) change from 
baseline 
[Range] 
-8.20 
(11.73) 
[-45  to 23] 
-5.16 (9.72) 
[-46  to 29] 
-3.01 (6.51) 
[ -20 to 15] 
-0.86 (5.45) 
[-31  to 19] 
-5.23 
(11.41) 
[-38 to 31] 
-3.06 (10.15) 
[-40 to 23] 
1.35 (3.69) 
[-14.5 to 
14.6] 
0.47 (3.40) 
[-28.0 to 
19.0] 
0.02 (7.21) 
[-28.1 to 
21.0] 
-0.40 (7.34) 
[-25.8 to 23.5] 
0.70 (9.10) 
[-28.1 to 
28.6] 
-1.38 (8.60) 
[-28.4 to 
25.1] 
6 monthsb             
n 265 622 260 607 252 598 252 596 249 590 249 590 
Mean (SD) 28.66 
(14.38) 
33.26 
(14.74) 
17.69 (8.69) 20.81 (8.89) 23.58 
(13.38) 
26.62 (13.71) 19.68 (4.24) 18.65 (4.08) 49.36 (10.80) 50.23 (10.38) 52.04 (9.48) 49.12 (9.28) 
[Range] [2 to 68] 
 
[0  to 68] [0 to 32] 
 
[0  to 32] [0 to 57] 
 
[0 to 60] [7 to 35] 
 
[7 to 35] [17.7 to 66.8] 
 
[19.9 to 67.2] [30.4 to 71.6] 
 
[26.2 to 74.4] 
 
Mean (SD) change from 
baseline 
[Range] 
-8.92 
(13.16) 
[-53  to 40] 
-5.70 
(10.59) 
[ -46  to 39] 
-4.04 (7.36) 
[-27  to 19] 
-1.00 (5.85) 
[-26  to 22] 
-5.21 
(11.36) 
[-38 to 27] 
-3.20 (10.86) 
[-43 to 27] 
1.67 (3.68) 
[-9.9 to 14.3] 
0.75 (3.60) 
[-25.6 to 
15.4] 
1.60 (6.82) 
[-17.7 to 
24.6] 
1.02 (7.47) 
[-28.0 to 33.8] 
0.01 (9.23) 
[-23.6 to 
30.2] 
-1.91 (8.76) 
[-29.9 to 
26.7] 
12 months             
n 349 710 335 699 328 690 327  683 322 674 322 674 
Mean (SD) 27.92 
(14.09) 
32.35 
(15.11) 
17.67 (9.23) 20.54 (9.01) 22.58 
(13.62) 
25.72 (13.22) 19.95 (4.35) 18.97 (4.22) 50.24 (10.03) 49.88 (10.67) 51.72 (9.59) 49.16 [9.21] 
[Range] [0 to 67] 
 
[0  to 66] [0 to 32] 
 
[0  to 32] [0 to 60] 
 
[0 to 60] [7 to 35] 
 
[7 to 35] [17.8 to 70.0] 
 
[13.7 to 69.3] [25.1 to 70.4] 
 
[27.0 to 73.0] 
Mean (SD) change from 
baseline 
[Range] 
-10.06 
(13.00) 
[-60 to 25] 
-6.97 
(11.65) 
[-47  to 37] 
-4.06 (7.97) 
[-30  to 22] 
-1.52 (6.53) 
[-29  to 21] 
-6.22 
(12.46) 
[-47 to 36] 
-4.39 (11.56) 
[-46 to 42] 
2.05 (4.03) 
[-8.8 to 20.3] 
1.11 (3.64) 
[-9.9 to 17.6] 
0.46 (7.70) 
[-23.6 to 
33.7] 
0.37 (8.27) 
[-32.5 to 35.3] 
0.65 (9.80) 
[-32.8 to 
31.8] 
-1.51 (9.55) 
[-33.4 to 
31.0] 
a Primary outcome 
bThere was an administrative error with the software sending automatic emails regarding questionnaire surveys which stopped working for about a month before it was spotted. Once this glitch was fixed the response period to have a ‘catch-up’ was extended from 4 
weeks to 8 weeks for those participants who were missed but most were too late. As a consequence, follow-up data of outcome measures at 3 and 6 months data were very low.   
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TABLE 3: ADJUSTED ESTIMATES FROM MIXED EFFECT MODEL FOR EACH OUTCOME AT 6 WEEKS AND 12 MONTHS AND 
ESTIMATES FROM THE CACE ANALYSIS AT 6 WEEKS 
Outcomes  Adjusted difference in mean change [95% CI] 
P-value 
mITT CACE 
SPIN-17a E-Couch vs Control (6 
weeks) 
 
-1.94 [-3.13 to -0.75]   
P=0.0014 
-2.95 [-4.30 to -1.61]  
P<0.0001 
E-Couch vs Control (12 
months) 
 
-3.07 [-4.32 to -1.82] 
P<0.0001 
N/A 
BFNE-S E-Couch vs Control (6 
weeks) 
 
-1.09 [-1.79 to -0.38] 
P=0.0026 
-1.60 [-2.38 to -0.82] 
 P<0.0001 
E-Couch vs Control (12 
months) 
 
-2.33 [-3.08 to -1.58] 
P<0.0001 
N/A 
SWEMWBS E-Couch vs Control (6 
weeks) 
 
0.38 [-0.02 to 0.77] 
P=0.0641 
0.59 [0.17 to 1.02] 
P=0.0060 
E-Couch vs Control (12 
months) 
 
0.82 [0.39 to 1.24] 
P=0.0001 
N/A 
CES-D E-Couch vs Control (6 
weeks) 
 
-3.35 [-4.54 to -2.15] 
P<0.0001 
 
N/A 
E-Couch vs Control (12 
months) 
 
-1.79 [-3.06 to -0.52] 
P=0.0056 
SF-36 (PCS) E-Couch vs Control (6 
weeks) 
 
0.398 [-0.41 to 1.20] 
P=0.3309 
 
N/A 
E-Couch vs Control (12 
months) 
 
0.003 [-0.85 to 0.85] 
P=0.9949 
SF-36 (MCS) E-Couch vs Control (6 
weeks) 
 
1.06 [0.12 to 1.98] 
P=0.0261 
 
N/A 
E-Couch vs Control (12 
months) 
 
2.06 [1.07 to 3.06] 
P<0.0001 
a Primary outcome 
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TABLE 4 COST UTILITY ANALYSIS OF SELF-GUIDED INTERNET-BASED E-COUCH INTERVENTION FOR SOCIAL ANXIETY 
SYMPTOMS  
Health status and QALY 
  Baseline   6 weeks   12 months  
 N SF-6D 
Mean (SD)  
N SF-6D 
Mean (SD)  
 N SF-6D 
Mean (SD) 
 
E-couch  1061 0.60 (0.10) 377 0.64 (0.12) 324 0.66 (0.12)  
Waiting list  1061 0.60 (0.10) 753 0.62 (0.11) 675 0.64 (0.12)  
        
    6 weeks  12 months  
      N Mean QALY (SD)  N  Mean QALY (SD)   
E-couch    377  0.072 (0.012) 324      0.635 (0.10)  
Waiting list    753 0.070 (0.011) 675  0.621 (0.10)  
        
Costs at 6 weeks and 12 months 
Health care 
utilisation 
costs and 
other costs at 
6 weeks  (£) 
N  GP attendance 
costs 
Mean (SD) 
Outpatient 
attendance 
costs 
Mean (SD) 
Inpatient costs 
Mean (SD) 
Cost of work 
days lost to 
sick leave 
Mean (SD)  
Mean health 
care cost (SD) 
Mean societal 
cost  
E-couch  383 38 (89.52) 45.43 
(123.99) 
72.77 (461.03) 106.65 
(476.99) 
156.19 (527.42) 425.30 
(1077.82) 
Waiting list  761 38.55 (65.89) 42.49 
(111.43) 
101.64 (570.51) 123.78 
(477.48) 
182.67 (643.67) 490.34 
(1264.51) 
        
Health care 
utilisation 
costs and 
other costs at 
12 months  (£) 
N  GP attendance 
costs 
Mean (SD) 
Outpatient 
attendance 
costs 
Mean (SD) 
Inpatient costs 
Mean (SD) 
Cost of work 
days lost to 
sick leave 
Mean (SD)  
Mean health 
care cost (SD) 
Mean societal 
cost (SD) 
E-couch  324 101.10 (152.66) 117.61 
(319.44) 
207.92 (864.18) 379.47 
(1740.74) 
425.30 
(1077.82) 
806.08 
(2198.79) 
Waiting list  680 106.34 (198.02) 141.84 
(416.68) 
242.16 
(1000.48) 
375.18 
(1248.74) 
490.34 
(1264.51) 
869.43 
(1823.07) 
 
 
